Recently GSK and Rentschler Biopharma SE announced they will expand existing and build new celltherapy genetherapy manufacturing capabilities at the CGT Catapult facility in Stevenage. The two companies will join other collaborators who are already present and progressing their product manufacturing onsite supported by UK Research and Innovation.